Table 1 General characteristics of targeted study population residing in each study village (n = 1973).

From: Factors hindering coverage of targeted mass treatment with primaquine in a malarious township of northern Myanmar in 2019–2020

General characteristics

PayKone (n = 207)

ManKat (n = 387)

PintSinTe (n = 393)

NantHnyin (n = 593)

NaungKan (n = 393)

Total

n (%)

n (%)

n (%)

n (%)

n (%)

Age (years)

  < 7

36 (17.4)

64 (16.5)

61 (15.5)

86 (14.5)

47 (12.0)

294 (14.9)

 7–14

49 (23.6)

75 (19.4)

107 (27.3)

111 (18.7)

81 (20.6)

423 (21.4)

 15–29

60 (29.0)

87 (22.5)

77 (19.6)

134 (22.7)

105 (26.7)

463 (23.5)

 30–44

34 (16.4)

71 (18.3)

72 (18.3)

131 (22.1)

81 (20.6)

389 (19.7)

 45–59

14 (6.8)

66(17.1)

56 (14.2)

75 (12.6)

49 (12.5)

260 (13.2)

  ≥ 60

14 (6.8)

24 (6.2)

20 (5.1)

56 (9.4)

30 (7.6)

144 (7.3)

Gender

 Male

74 (35.7)

146 (37.7)

181 (46.1)

232 (39.1)

209 (53.2)

842 (42.7)

 Female

133 (64.3)

241 (62.3)

212 (53.9)

361 (60.9)

184 (46.8)

1131 (57.3)

Ethnicity

 Burmese

5 (2.4)

38 (9.8)

45 (11.5)

10 (1.7)

20 (5.1)

118 (6.0)

 Kadu

197 (95.2)

373 (94.9)

570 (28.9)

 Kanan

561 (94.6)

561 (28.4)

 Shan

5 (2.4)

349 (90.2)

348 (88.5)

22 (3.7)

724 (36.7)

G6PD status

 Normal

193 (93.2)

324 (83.7)

344 (87.5)

499 (84.1)

347 (88.3)

1707 (86.5)

 Deficient

14 (6.8)

63 (16.3)

49 (12.5)

94 (15.9)

46 (11.7)

266 (13.5)

Pregnancy/Breastfeeding

 Yes

3 (1.4)

10 (2.6)

16 (4.1)

18 (3.0)

4 (1.0)

51 (2.6)

 No

204 (98.6)

377 (97.4)

377 (95.9)

575 (97.0)

389 (99.0)

1922 (97.4)

Hemoglobin value (g/dl)

  < 8

4 (1.9)

15 (3.9)

14 (3.6)

21 (3.5)

14 (3.6)

68 (3.4)

  ≥ 8

203 (98.1)

372 (96.1)

379 (96.4)

572 (96.5)

379 (96.4)

1905 (96.6)